Aura Biosciences (AURA) Research & Development (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Research & Development data on file, last reported at $28.0 million in Q1 2026.

• Quarterly Research & Development rose 19.78% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.9 million (up 19.25% YoY) and the FY2025 annual result came in at $90.3 million, up 23.19% from the prior year.
• Research & Development improved to $28.0 million in Q1 2026, from $21.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $28.0 million in Q1 2026 to a low of $8.3 million in Q1 2022.
• A 5-year average of $17.6 million and a median of $17.0 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development soared 97.75% — and 2025, when it slipped 1.96%.
• Tracing AURA's Research & Development over 5 years: stood at $13.2 million in 2022, then jumped by 54.12% to $20.3 million in 2023, then grew by 10.13% to $22.3 million in 2024, then fell by 1.96% to $21.9 million in 2025, then advanced by 27.69% to $28.0 million in 2026.
• The last three Research & Development figures came in at $28.0 million (Q1 2026), $21.9 million (Q4 2025), and $22.2 million (Q3 2025), per Business Quant data.